Jiangsu Hengrui Pharmaceuticals (01276) recommends adopting the 2026 A-share employee stock ownership plan.

Jiangsu Hengrui Pharmaceuticals (01276) announced in a notice that its Board of Directors has approved the employee stock ownership plan during a board meeting held on August 19, 2026. The implementation of the employee stock ownership plan is subject to approval by the company's shareholders' meeting before taking effect. The purpose of this plan is to establish and improve the mechanism for sharing the interests of the company, shareholders, and employees, motivate employees' enthusiasm and creativity, enhance employee cohesion and the company's competitiveness, and promote the long-term, sustainable, and healthy development of the company.